NOVOB80:BKK
NOVOB80 KTB DR
THB 1.28
arrow_upward
+0.79%(+0.0100) 1D
Oct 10, 2:58:27 AM GMT+7 · THB
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVOB80...
Open
THB 1.28
High
THB 1.29
Low
THB 1.27
Mkt. cap
128.45B
Avg. vol.
4.00M
Volume
1.21M
52-wk high
THB 2.02
52-wk low
THB 1.12
Shares outstanding
3.00B
No. of employees
67K
Open
THB 1.28
High
THB 1.29
Low
THB 1.27
Mkt. cap
128.45B
Avg. vol.
4.00M
Volume
1.21M
52-wk high
THB 2.02
52-wk low
THB 1.12
Shares outstanding
3.00B
No. of employees
67K
News stories
From web sources and news partners
Simply Wall Street
·
8 hours ago
Novo Nordisk (NVO) Stock May Trade Below Fair Value After GLP 1 Expansion Plans
Traders Union
·
1 day ago
Novo Nordisk stock support test at $37.43: Technical outlook
Investing.com
·
1 day ago
Novo Nordisk stock target cut at Citi on lack of margin growth
The Motley Fool
·
1 day ago
UBS Called Novo Nordisk a 'Value Trap.' Here's the Other Side of That Argument.
Profile
Novo is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark's domestic economy, and it became the highest valued company in Europe. Wikipedia
About NOVOB80 KTB DR
CEOMaziar Mike Doustdar
Employees66.7K
FoundedDec 21, 1923
HeadquartersBagsværd, Capital Region of Denmark, Denmark
SectorPharmaceutical industry
Websitenovonordisk.com